Your browser doesn't support javascript.
loading
A recurrent, de novo pathogenic variant in ARPC4 disrupts actin filament formation and causes microcephaly and speech delay.
Laboy Cintron, Dianne; Muir, Alison M; Scott, Abbey; McDonald, Marie; Monaghan, Kristin G; Santiago-Sim, Teresa; Wentzensen, Ingrid M; De Luca, Chiara; Brancati, Francesco; Harris, David J; Goueli, Cecilia; Stottmann, Rolf; Prada, Carlos E; Biderman Waberski, Marta; Mefford, Heather C.
Afiliação
  • Laboy Cintron D; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA.
  • Muir AM; Department of Pediatrics, Division of Genetic Medicine, University of Washington, Seattle, WA, USA.
  • Scott A; Division of Genetic Medicine, Seattle Children's Hospital, Seattle, WA, USA.
  • McDonald M; Department of Pediatrics, Duke University, Durham, NC, USA.
  • Monaghan KG; GeneDx, Inc, 207 Perry Parkway, Gaithersburg, MD, USA.
  • Santiago-Sim T; GeneDx, Inc, 207 Perry Parkway, Gaithersburg, MD, USA.
  • Wentzensen IM; GeneDx, Inc, 207 Perry Parkway, Gaithersburg, MD, USA.
  • De Luca C; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Brancati F; Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
  • Harris DJ; IRCCS San Raffaele Roma, 00163 Roma, Italy.
  • Goueli C; Division of Genetics and Genomics, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
  • Stottmann R; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA.
  • Prada CE; Nationwide Children's Hospital, Columbus, OH, USA.
  • Biderman Waberski M; Department of Pediatrics, Cincinnati Children's Hospital, Cincinnati, OH, USA.
  • Mefford HC; Division of Genetics, Birth Defects and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA.
HGG Adv ; 3(1): 100072, 2022 Jan 13.
Article em En | MEDLINE | ID: mdl-35047857
We report seven affected individuals from six families with a recurrent, de novo variant in the ARPC4 gene (c.472C>T [p.Arg158Cys (GenBank: NM_005718.4)]). Core features in affected individuals include microcephaly, mild motor delays, and significant speech impairment. ARPC4 is a core subunit of the actin-related protein (ARP2/3) complex, which catalyzes the formation of F-actin networks. We show that the recurrent ARPC4 missense change is associated with a decreased amount of F-actin in cells from two affected individuals. Taken together, our results implicate heterozygous ARPC4 missense variants as a cause of neurodevelopmental disorders and microcephaly.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article